TPG Group Holdings (SBS) Advisors’s Trevi Therapeutics TRVI Stock Holding History

TPG Group Holdings (SBS) Advisors’s Portfolio TRVI Stock Details TRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$6.75M	Hold	4,824,883	–	–	0.07%	40
2021 Q2	$10.9M	Hold	4,824,883	–	–	0.08%	43
2021 Q1	$13.1M	Hold	4,824,883	–	–	0.15%	37
2020 Q4	$11.7M	Hold	4,824,883	–	–	0.13%	34
2020 Q3	$19.4M	Hold	4,824,883	–	–	0.35%	33
2020 Q2	$31.7M	Sell	4,824,883 -1,499,436	-24%	-$5.28M	0.56%	32
2020 Q1	$20.8M	Hold	6,324,319	–	–	0.48%	29
2019 Q4	$23.7M	Hold	6,324,319	–	–	0.35%	32
2019 Q3	$28.5M	Hold	6,324,319	–	–	0.42%	34
2019 Q2	$47.4M	Buy	+6,324,319	New	+$54.5M	0.71%	29

Other funds holding TRVI

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors's TRVI Position: Q3 2021 in Review

TPG Group Holdings (SBS) Advisors held its Trevi Therapeutics (TRVI) position steady in Q3 2021 at 4,824,883 shares worth $6.75M. The position accounts for 0.07% of the portfolio, ranked #40.

TPG Group Holdings (SBS) Advisors first reported a position in TRVI in Q2 2019 and has held it in 10 quarters since. The position peaked at $47.4M in Q2 2019. 18 funds tracked by Wall St. Rank hold TRVI as of Q3 2021.

TPG Group Holdings (SBS) Advisors held 4,824,883 shares of Trevi Therapeutics worth $6.75M as of Q3 2021.
TPG Group Holdings (SBS) Advisors left its Trevi Therapeutics share count unchanged in Q3 2021.
Trevi Therapeutics made up 0.07% of TPG Group Holdings (SBS) Advisors's portfolio in Q3 2021, its #40 holding.
TPG Group Holdings (SBS) Advisors first reported a position in Trevi Therapeutics in Q2 2019 and has held it in 10 quarters since.
TPG Group Holdings (SBS) Advisors's Trevi Therapeutics position peaked at $47.4M in Q2 2019.
18 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2021.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.